Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has been given a $17.00 price objective by investment analysts at Jefferies Group LLC in a note issued to investors on Friday. The firm currently has a “buy” rating on the software maker’s stock. Jefferies Group LLC’s target price would suggest a potential upside of 31.38% from the stock’s previous close.

MDRX has been the topic of a number of other research reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $17.00 target price (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a research report on Monday, August 14th. Bank of America Corporation began coverage on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. They issued a “neutral” rating and a $14.00 target price on the stock. Citigroup Inc. upped their target price on shares of Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the company a “neutral” rating in a research report on Monday, August 7th. BidaskClub raised shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, June 24th. Finally, Leerink Swann cut shares of Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and decreased their target price for the company from $15.00 to $13.00 in a research report on Monday, June 19th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have issued a buy rating to the company’s stock. Allscripts Healthcare Solutions presently has an average rating of “Hold” and a consensus price target of $14.63.

Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at 12.94 on Friday. The firm has a 50 day moving average of $12.55 and a 200-day moving average of $12.26. The stock’s market cap is $2.34 billion. Allscripts Healthcare Solutions has a 52-week low of $9.80 and a 52-week high of $13.70.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.15 by $0.04. The firm had revenue of $426.10 million for the quarter, compared to analyst estimates of $424.94 million. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The company’s revenue was up 10.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.14 EPS. Equities analysts anticipate that Allscripts Healthcare Solutions will post $0.62 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Allscripts Healthcare Solutions, Inc. (MDRX) PT Set at $17.00 by Jefferies Group LLC” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/26/allscripts-healthcare-solutions-inc-mdrx-pt-set-at-17-00-by-jefferies-group-llc.html.

Hedge funds have recently added to or reduced their stakes in the company. TimesSquare Capital Management LLC raised its stake in Allscripts Healthcare Solutions by 1,322.5% in the second quarter. TimesSquare Capital Management LLC now owns 4,039,900 shares of the software maker’s stock worth $51,549,000 after buying an additional 3,755,900 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Allscripts Healthcare Solutions by 26.9% in the second quarter. Dimensional Fund Advisors LP now owns 9,171,285 shares of the software maker’s stock worth $117,026,000 after buying an additional 1,943,496 shares during the last quarter. First Trust Advisors LP raised its stake in Allscripts Healthcare Solutions by 48.0% in the first quarter. First Trust Advisors LP now owns 5,855,944 shares of the software maker’s stock worth $74,253,000 after buying an additional 1,898,007 shares during the last quarter. Mesirow Financial Investment Management Equity Management purchased a new stake in Allscripts Healthcare Solutions during the second quarter worth $18,797,000. Finally, Fiduciary Management Inc. WI raised its stake in Allscripts Healthcare Solutions by 28.5% in the first quarter. Fiduciary Management Inc. WI now owns 6,045,110 shares of the software maker’s stock worth $76,652,000 after buying an additional 1,341,870 shares during the last quarter.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.